BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2000
View Archived Issues
Researchers identify new nuclear receptor targets for cholesterol control
Read More
Niacin safely controls lipid disorders in diabetic patients
Read More
Cantab increases products in clinical development to six during first half 2000
Read More
Orally active partial D2 agonist may have potential in PD and schizophrenia
Read More
Cel-Sci receives grant for cervical cancer study with Multikine
Read More
Promising data reported from phase II trial of injectable anticoagulant
Read More
Maxamine scheduled for December advisory panel review
Read More
Sangamo establishes collaboration with Merck & Co.
Read More
New formulation of Zyprexa introduced for psychotic disorders and manic episodes
Read More
Agouron commences additional capravirine clinical trial
Read More
FDA approves QVAR Inhalation Aerosol for treatment of asthma
Read More
Preclinical activity, pharmacokinetics and toxicity reported for novel parenteral carbapenem
Read More
BMS-247243, a new anti-MRSA cephem, debuts at ICAAC
Read More
Sankyo presents preclinical profile of promising new triazole antifungal agent
Read More
Candidate for Rx of Gram-positive infections selected at Daiichi
Read More
ICAAC news: first report of potential anti-flu agent with novel mode of action
Read More
First selective orexin-1 receptor antagonists emerge from R&D program at SB
Read More
Several related series described by Bayer as useful for anemia Rx
Read More
AHP synthesizes and evaluates new PTPase inhibitors
Read More
Serotonergic agents, their activity and therapeutic uses disclosed by ADIR
Read More
uPAR antagonists claimed by Roche Diagnostics as antitumor/antimetastatic agents
Read More
BASF presents new cysteine protease inhibitors and their therapeutic use
Read More
New broad-spectrum antibacterial agents derived from erythromycin
Read More
Matrix metalloproteinase-inhibitory compounds described in recent patent
Read More
Novartis presents new NK1 receptor antagonists with potential for pain and migraine
Read More
Therapies for obesity, diabetes under investigation at Dainippon
Read More
Elan to acquire Dura
Read More